Abstract
The German health system represents the case of a global budget with negotiated fees and competing medical insurance companies. Physicians in private practice and non-profit dialysis provider associations provide most dialysis therapy. End-stage renal disease (ESRD) modalities are well integrated into the overall health care system. Dialysis therapy, independent of the mode of treatment, is reimbursed at a weekly flat rate. Mandatory health insurance covers health expenses, including those related to ESRD, for more than 90% of the population. Both employees and employers contribute to the premium for this insurance. Private medical insurance covers the remainder of the population. Access to treatment, including dialysis therapy, is uniformly available.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashton, T., & Marshall, M. R. (2007). The organization and financing of dialysis and kidney transplantation services in New Zealand. International Journal of Health Care Finance and Economics. DOI 10.1007/s10754-007-9023-x
Busse, R. (2003). Professor of Health Care Management, Technische Universität Berlin, lecture March 10, 2003, London, European Observatory on Health Care Systems : The German Healthcare System in a Nutshell.
Cass A., Chadban S., Craig J., Howard K., McDonald S., Salkeld G., White S. (2006) The economic impact of end stage kidney disease in Australia. The George Institute for International Health, Sydney, Australia
Dor, A., Pauly, M. V., Eichleay, M. A., & Held, P. J. (2007). End-stage renal disease and economic incentives: The Internaional Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Financing and Economics. DOI 10.1007/s10754-007-9024-9
Durand-Zaleski, I., Combe, C., & Lang, P. (2007). International study of health care organization and financing for end-stage renal disease in France. International Journal of Health Care Finance and Economics. DOI 10.1007/s10754-007-9025-8
Frei, U., & Schober-Halstenberg, H.-J. (2002). Annual Report on Dialysis Treatment and Renal Transplantation in Germany for 2001/2002. Retrieved March 13, 2007, from http://www.quasi-niere.de/berichte/online/en/01/world.html.
Frei, U., & Schober-Halstenberg, H.-J. (2004). Renal replacement therapy in Germany 2003/2004. Retrieved March 13, 2007, from http://www.quasi-niere.de/berichte/online/en/03/world.html.
Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI 10.1007/s10754-007-9019-6
Huber, M., & Lafortune, G. (2003). Health at a Glance–OECD Indicators 2003: Briefing Note (Germany). Retrieved November 1, 2005, from http://www.oecd.org/dataoecd/15/30/16782333.pdf.
International Reform Monitor (2005). Health-care and long-term care (Germany). Gütersloh: Bertelsmann Stiftung Foundation. Retrieved November 1, 2005, from http://www.bertelsmann-stiftung.org/downloads/health.
Lee H., Manns B.J., Taub K., Ghali W., Dean S., Johnsom D., Donaldson C. (2002) Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 40: 611–622
Luño, J. (2007). The organization and financing of end-stage renal disease in Spain. International Journal of Health Care Finance and Economics DOI 10.1007/s10754-007-9021-z
Nicholson, T., & Roderick, P. (2007). International study of health care organization and financing of renal services in England and Wales. International Journal of Health Care Finance and Economics. DOI 10.1007/s10754-007-9015-x
OECD (2006). Purchasing Power Parities (PPPs) for OECD Countries 1980–2005. Retrieved April 28, 2006, from http://www.oecd.org/statisticsdata/0,2643,en_2649_34357_1_119656_1_1_1,00.html.
OECD (2005). OECD in Figures – 2005 Edition: Health Spending and Resources. Paris: Organization for Economic Cooperation and Development. CD Rom.
Pisoni R.L., Bragg-Gresham J.L., Young E.W., Akizawa T., Asano Y., Locatelli F., Bommer J., Cruz J.M., Kerr P.G., Mendelssohn D.C., Held P.J., Port F.K. (2004) Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 44(1): 94–111
Pontoriero, G., Pozzoni, P., Del Vecchio, L., & Locatelli, F. (2007). International study of health care organization and financing of renal replacement therapy in Italy: An evolving reality. International Journal of Health Care Finance and Economics. DOI 10.1007/s10754-007-9016-9
Rayner H., Pisoni R.L., Bommer J., Canaud B., Hecking E., Locatelli F., Piera L., Bragg-Gresham J.L., Feldman H.I., Goodkin D.A., Gillespie B., Wolfe R.A., Held P.J., Port F.K. (2004) Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis and Transplantation 19: 108–120
REIN Studie & Dialyse Fachtagung Symposium. http://www.kieler-nierenwoche.de/seiten/14.reinstudie.html.
Techniker Krankenkasse (2006). Retrieved October 16, 2006 from, www.tk-online.de/centaurus/generator/tk-online.de/dossiers/organspende/070-nierentransplantation/17.
U.S. Renal Data System (USRDS). (2002). Annual Data Report: Atlas of end-stage renal disease in the United States. Bethesda MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
USRDS (2004). U.S. Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Van Biesen, W., Lameire, N., Peeters, P., & Vanholder, R. (2007). Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease. International Journal of Health Care Finance and Economics. DOI 10.1007/s10754-007-9013-z
Wikstöm, B., Fored, M., Eichleay, M. A., & Jacobson, S. H. (2007). The financing and organization of medical care for patients with end-stage renal disease in Sweden. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-9013-y
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kleophas, W., Reichel, H. International study of health care organization and financing: development of renal replacement therapy in Germany. Int J Health Care Finance Econ 7, 185–200 (2007). https://doi.org/10.1007/s10754-007-9020-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10754-007-9020-0